Adalyon Appoints Ulrik Zeuthen as CEO
Adalyon, a pioneering tech-bio firm utilizing its AI-powered speech biomarker platform to remodel scientific drug growth, at present introduced the appointment of Ulrik Zeuthen, as Chief Executive Officer (CEO). Ulrik is an skilled chief in driving digital transformation within the pharmaceutical trade by way of information integration and synthetic intelligence (AI). Adalyon’s proprietary speech-based digital…
